Published in J Natl Cancer Inst on January 17, 2001
Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents. Tob Control (2002) 5.86
Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol (2009) 4.16
Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ (2014) 2.83
Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence. Tob Control (2001) 2.24
What happened to smokers' beliefs about light cigarettes when "light/mild" brand descriptors were banned in the UK? Findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2008) 2.09
Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents. Tob Control (2011) 2.02
Hazardous compounds in tobacco smoke. Int J Environ Res Public Health (2011) 1.75
Toward a comprehensive long term nicotine policy. Tob Control (2005) 1.52
Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol (2009) 1.52
Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy. Tob Control (2007) 1.46
Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control (2001) 1.38
Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology (2003) 1.31
Trends in sales weighted tar, nicotine, and carbon monoxide yields of UK cigarettes. Thorax (2001) 1.30
Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents. Tob Control (2006) 1.15
Is consumer response to plain/standardised tobacco packaging consistent with framework convention on tobacco control guidelines? A systematic review of quantitative studies. PLoS One (2013) 1.13
Cigarette nicotine yields and nicotine intake among Japanese male workers. Tob Control (2002) 1.05
Cessation among smokers of "light" cigarettes: results from the 2000 national health interview survey. Am J Public Health (2006) 1.04
A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology (Berl) (2006) 1.04
Dependence of tar, nicotine and carbon monoxide yields on physical parameters: implications for exposure, emissions control and monitoring. Tob Control (2007) 1.01
Tobacco and nicotine product testing. Nicotine Tob Res (2011) 0.96
Switching to "lighter" cigarettes and quitting smoking. Tob Control (2009) 0.96
gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products. Mutat Res (2009) 0.91
Research priorities for FCTC Articles 20, 21, and 22: surveillance/evaluation and information exchange. Nicotine Tob Res (2013) 0.88
Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies. Crit Rev Toxicol (2012) 0.87
Smoking cigarettes of low nicotine yield does not reduce nicotine intake as expected: a study of nicotine dependency in Japanese males. BMC Public Health (2004) 0.83
Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells. Infect Immun (2003) 0.82
Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts. J Cell Biochem (2005) 0.81
The most important and influential papers in tobacco control: results of an online poll. Tob Control (2005) 0.81
Smoking topography and biomarkers of exposure among Japanese smokers: associations with cigarette emissions obtained using machine smoking protocols. Environ Health Prev Med (2012) 0.80
Threshold dose for discrimination of nicotine via cigarette smoking. Psychopharmacology (Berl) (2016) 0.79
Mouth Level Exposure and Similarity to Machine-smoked Constituent Yields. Tob Regul Sci (2016) 0.78
Saliva as a matrix for human biomonitoring in occupational and environmental medicine. Int Arch Occup Environ Health (2014) 0.78
The fallacy of "light" cigarettes. BMJ (2004) 0.78
Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Exp Clin Psychopharmacol (2010) 0.77
Nicotine content of domestic cigarettes, imported cigarettes and pipe tobacco in iran. Addict Health (2014) 0.75
Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health (1987) 8.59
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J (1980) 4.76
Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health (1984) 3.95
Improved gas chromatographic method and micro-extraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol (1979) 3.72
Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) (1982) 2.92
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 2.91
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. BMJ (1989) 2.81
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction (1995) 2.71
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health (1988) 2.63
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol (1980) 2.43
Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41
Cigarette smoking: a dependence on high-nicotine boli. Drug Metab Rev (1978) 2.36
Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict (1987) 2.33
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
Rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst (1980) 2.29
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health (1992) 2.17
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders. Clin Pharmacol Ther (1978) 2.09
A new age for snuff? Lancet (1980) 2.06
Exposure to passive smoking among bar staff. Br J Addict (1992) 2.06
Blood and Urinary nicotine in non-smokers. Lancet (1975) 2.01
Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet (1992) 2.00
Reduction of tar, nicotine and carbon monoxide intake in low tar smokers. J Epidemiol Community Health (1986) 1.98
Comparison of nicotine chewing-gum and psychological treatments for dependent smokers. Br Med J (1980) 1.96
Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors? Arch Dis Child (2005) 1.89
Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet (1973) 1.84
Passive exposure to tobacco smoke in children aged 5-7 years: individual, family, and community factors. BMJ (1994) 1.82
Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) (1992) 1.73
Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. Thorax (1983) 1.70
The relationship of salivary cotinine to respiratory symptoms, spirometry, and exercise-induced bronchospasm in seven-year-old children. Am Rev Respir Dis (1990) 1.65
Relation of passive smoking as assessed by salivary cotinine concentration and questionnaire to spirometric indices in children. Thorax (1993) 1.65
Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation? Br Med J (Clin Res Ed) (1983) 1.65
Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J (Clin Res Ed) (1982) 1.59
Advising parents of asthmatic children on passive smoking: randomised controlled trial. BMJ (1999) 1.57
Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J (2004) 1.56
Cardiovascular medication, physical activity and mortality: cross-sectional population study with ongoing mortality follow-up. Heart (2008) 1.55
Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl) (1992) 1.53
Children's emotional and behavioural well-being and the family environment: findings from the Health Survey for England. Soc Sci Med (2001) 1.51
A rapid gas-liquid chromatographic estimation of nicotine in biological fluids. J Pharm Pharmacol (1975) 1.49
Long-term switching to low-tar low-nicotine cigarettes. Br J Addict (1982) 1.47
Blood lead and blood pressure: evidence from the Health Survey for England 1995. J Hum Hypertens (1999) 1.42
Determinants and effects of attentional bias in smokers. Psychol Addict Behav (2000) 1.42
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Arch Fam Med (1993) 1.41
Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control (2001) 1.38
Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth (2001) 1.38
Smoke-free homes in England: prevalence, trends and validation by cotinine in children. Tob Control (2009) 1.36
Nicotine chewing gum as a substitute for smoking. Br Med J (1977) 1.36
Nicotine intake by snuff users. Br Med J (Clin Res Ed) (1981) 1.35
Factors determining exposure to passive smoking in young adults living at home: quantitative analysis using saliva cotinine concentrations. Int J Epidemiol (1991) 1.30
Assessment of environmental tobacco smoke exposure in children with asthmatic symptoms by questionnaire and cotinine concentrations in plasma, saliva, and urine. J Clin Epidemiol (2000) 1.28
The stability of cotinine in unfrozen saliva mailed to the laboratory. Am J Public Health (1994) 1.27
Nasal nicotine solution: a potential aid to giving up smoking? Br Med J (Clin Res Ed) (1983) 1.25
Passive smoking in adolescents: one-year stability of exposure in the home. Lancet (1987) 1.23
Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochem Biophys Res Commun (2001) 1.23
Effect of nicotine replacement on the cigarette withdrawal syndrome. Br J Addict (1984) 1.22
Determination of cotinine in biological fluids of non-smokers by packed column gas-liquid chromatography. J Pharm Pharmacol (1986) 1.22
Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology (Berl) (1986) 1.19
Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects? Psychopharmacology (Berl) (1984) 1.17
B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines. Clin Immunol Immunopathol (1989) 1.16
The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer (1994) 1.15
Birthweight and behavioural problems in children: a modifiable effect? Int J Epidemiol (2001) 1.14
Effect of ulcerative colitis and smoking on rectal blood flow. Gut (1990) 1.13
Ethnic inequalities in access to and outcomes of healthcare: analysis of the Health Survey for England. J Epidemiol Community Health (2009) 1.10
Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis (2009) 1.10
Buccal absorption of nicotine from smokeless tobacco sachets. Lancet (1985) 1.08
Images of a lipid bilayer at molecular resolution by scanning tunneling microscopy. Proc Natl Acad Sci U S A (1987) 1.08
Induction of autoimmunity with dendritic cells: studies on thyroiditis in mice. Clin Immunol Immunopathol (1988) 1.08
Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum. Infect Immun (1992) 1.06
Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut (1994) 1.05
A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. Am J Med (1988) 1.05
Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology (Berl) (1983) 1.03
Hampshire depression project: changes in the process of care and cost consequences. Br J Gen Pract (2001) 1.03
Nicotine enemas for active ulcerative colitis--a pilot study. Aliment Pharmacol Ther (1997) 1.01
Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med (1995) 1.00
Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol (1976) 1.00
Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect Immun (1993) 0.99
Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. BMJ (1996) 0.98
Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults. Heart (2010) 0.98
Smokers' response to shortened cigarettes: dose reduction without dilution of tobacco smoke. Clin Pharmacol Ther (1980) 0.96
Nicotine pharmacokinetics and its application to intake from smoking. Br J Clin Pharmacol (1985) 0.96
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Cancer Res (1994) 0.96
Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med (1994) 0.93
A smoking cessation programme conducted through dental practices in the UK. Br Dent J (1998) 0.93
In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol (1996) 0.93
Nicotine availability from Eclipse tobacco-heating cigarette. Psychopharmacology (Berl) (1998) 0.92
Barriers to employment among working-aged patients with major burn injury. J Burn Care Rehabil (2001) 0.92
Genetic characterization of gram-positive homologs of the XerCD site-specific recombinases. J Mol Microbiol Biotechnol (2000) 0.92
Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochem Biophys Res Commun (2000) 0.91
Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients. Int J Pharm (2008) 0.91
Clinical status of ulcerative colitis in patients who smoke. Am J Gastroenterol (1998) 0.89